Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App




Novel System Enables Lightning Fast Transport of Clinical Samples

By LabMedica International staff writers
Posted on 10 Aug 2023

Time plays a major role in the effective transportation of clinical samples. More...

Traditional methods of transporting these samples, like blood, urine, and swabs, from departments to labs often prove unpredictable with high variation. Now, an innovative system with one-touch enables lightning-fast transport of small clinical samples. With blood samples comprising about 75% of the items dispatched through traditional tube systems, the novel system significantly reduces the strain on existing pneumatic tube systems.

Sarstedt (Nümbrecht, Germany) has developed the Tempus600 system to increase the efficiency of sample transportation. The system facilitates one-touch handling and point-to-point delivery, leading to a significant reduction in the total turnaround time (ToTAT) from when the test is ordered to reporting the analysis result to the concerned clinician. In addition to supporting the transition to increased ambulatory treatments in hospitals and clinics, Tempus600 also aids in the efficient treatment and quicker discharge of hospitalized patients.

The Tempus600 system features a dedicated point-to-point line of 25 mm tubes without any cross points in the system, thus eliminating the risk of samples getting blocked. Samples arrive seamlessly from the ward to the lab in mere seconds without the hassles of packing, unpacking, delays, or mix-ups. Boasting an hourly capacity of up to 1250 samples, it significantly eases the pressure on existing transport systems and frees up capacity for transporting materials in addition to small clinical samples. The Tempus600 system can be installed in a hospital or building in two weeks without causing any disruptions to a hospital’s daily operations.

With the Tempus600, hospital staff is no longer burdened with hand-delivering samples or relying on traditional systems, allowing them to channel their valuable skills where they are most needed. Nurses can dedicate more time to patient care, while lab technicians can focus on collecting and examining samples. The outcome is improved results and faster, superior treatment. With the fast and dedicated pipeline offered by Tempus600, labs function optimally, eliminating the need for remote laboratories. This improved efficiency translates to faster analyses, better patient care, and a significant reduction in bed days.

Related Links:
Sarstedt


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Immunofluorescence image of reactive astrocytes (red) in the area surrounding sEcad-high cancer cells (blue, center) (Photo courtesy of Debeb Laboratory)

Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis

Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.